| a-SMA | Alpha-smooth muscle actin |
| ALT | Alanine aminotransferase |
| AST | Aspartate aminotransferase |
| CAP | Controlled attenuation parameter |
| Col1a1 | Collagen 1a1 |
| GLP-1 | Glucagon-like peptide 1 |
| H&E | Hematoxylin-eosin |
| HOMA-IR | Homeostatic model assessment of insulin resistance |
| IHC | Immunohistochemistry |
| ipITT | Intraperitoneal insulin tolerance test |
| KITT | Calculated plasma glucose disappearance rate |
| NAFL | Non-alcoholic fatty liver |
| NAFLD | Non-alcoholic fatty liver disease |
| NAS | NAFLD activity score |
| NASH | Non-alcoholic steatohepatitis |
| OGTT | Oral glucose tolerance test |
| PLS-DA | Partial least squares-discriminant analysis |
| QUICKI | Quantitative insulin sensitivity check index |
| RCT | Randomized controlled trial |
| SGLT2i | Sodium-glucose cotransporter 2 inhibitors |
| SPMs | Pro-resolving mediators |
| T2DM | Type 2 diabetes mellitus |